These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
518 related items for PubMed ID: 20797448
21. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells. Tolstikov V, Nikolayev A, Dong S, Zhao G, Kuo MS. PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521 [Abstract] [Full Text] [Related]
22. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Barger JF, Plas DR. Endocr Relat Cancer; 2010 Dec; 17(4):R287-304. PubMed ID: 20699334 [Abstract] [Full Text] [Related]
23. Energy metabolism in tumor cells. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. FEBS J; 2007 Mar; 274(6):1393-418. PubMed ID: 17302740 [Abstract] [Full Text] [Related]
24. 'The metabolism of tumours': 70 years later. Semenza GL, Artemov D, Bedi A, Bhujwalla Z, Chiles K, Feldser D, Laughner E, Ravi R, Simons J, Taghavi P, Zhong H. Novartis Found Symp; 2001 Mar; 240():251-60; discussion 260-4. PubMed ID: 11727934 [Abstract] [Full Text] [Related]
25. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma. Neurath KM, Keough MP, Mikkelsen T, Claffey KP. Glia; 2006 May; 53(7):733-43. PubMed ID: 16518831 [Abstract] [Full Text] [Related]
26. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Mazurek S. Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581 [Abstract] [Full Text] [Related]
27. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Feron O. Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589 [Abstract] [Full Text] [Related]
28. Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor alpha/retinoid X receptor. Belanger AJ, Luo Z, Vincent KA, Akita GY, Cheng SH, Gregory RJ, Jiang C. Biochem Biophys Res Commun; 2007 Dec 21; 364(3):567-72. PubMed ID: 17963722 [Abstract] [Full Text] [Related]
29. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Pathania D, Millard M, Neamati N. Adv Drug Deliv Rev; 2009 Nov 30; 61(14):1250-75. PubMed ID: 19716393 [Abstract] [Full Text] [Related]
30. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. Jezek P, Plecitá-Hlavatá L, Smolková K, Rossignol R. Int J Biochem Cell Biol; 2010 May 30; 42(5):604-22. PubMed ID: 19931409 [Abstract] [Full Text] [Related]
31. (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. Weljie AM, Bondareva A, Zang P, Jirik FR. J Biomol NMR; 2011 Apr 30; 49(3-4):185-93. PubMed ID: 21373841 [Abstract] [Full Text] [Related]
32. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment. Seo J, Yun JE, Kim SJ, Chun YS. Pflugers Arch; 2022 Jun 30; 474(6):591-601. PubMed ID: 35348849 [Abstract] [Full Text] [Related]
33. Dynamic metabolic transformation in tumor invasion and metastasis in mice with LM-8 osteosarcoma cell transplantation. Hua Y, Qiu Y, Zhao A, Wang X, Chen T, Zhang Z, Chi Y, Li Q, Sun W, Li G, Cai Z, Zhou Z, Jia W. J Proteome Res; 2011 Aug 05; 10(8):3513-21. PubMed ID: 21661735 [Abstract] [Full Text] [Related]
34. Metabolomics of cancer. Serkova NJ, Glunde K. Methods Mol Biol; 2009 Aug 05; 520():273-95. PubMed ID: 19381962 [Abstract] [Full Text] [Related]
35. Metabolic signatures of malignant progression in prostate epithelial cells. Teahan O, Bevan CL, Waxman J, Keun HC. Int J Biochem Cell Biol; 2011 Jul 05; 43(7):1002-9. PubMed ID: 20633696 [Abstract] [Full Text] [Related]
36. Proteomics revisits the cancer metabolome. Hu H, Deng C, Yang T, Dong Q, Chen Y, Nice EC, Huang C, Wei Y. Expert Rev Proteomics; 2011 Aug 05; 8(4):505-33. PubMed ID: 21819305 [Abstract] [Full Text] [Related]
37. An update on therapeutic opportunities offered by cancer glycolytic metabolism. Granchi C, Fancelli D, Minutolo F. Bioorg Med Chem Lett; 2014 Nov 01; 24(21):4915-25. PubMed ID: 25288186 [Abstract] [Full Text] [Related]
38. Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells. Armitage EG, Kotze HL, Allwood JW, Dunn WB, Goodacre R, Williams KJ. Sci Rep; 2015 Oct 28; 5():15649. PubMed ID: 26508589 [Abstract] [Full Text] [Related]
39. Cancer cell metabolism and developmental homeodomain/POU domain transcription factors: a connecting link. Purkayastha BP, Roy JK. Cancer Lett; 2015 Jan 28; 356(2 Pt A):315-9. PubMed ID: 24909495 [Abstract] [Full Text] [Related]
40. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming. Eng CH, Abraham RT. Oncogene; 2011 Nov 24; 30(47):4687-96. PubMed ID: 21666712 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]